Embecta Corp. did not undergo a subsequent corporate rebranding or name change following its initial establishment as an independent entity. The name "embecta" was selected at the time of its tax-free spin-off from Becton, Dickinson and Company to reflect its specialized focus on diabetes care and injection devices, maintaining that distinct corporate identity across global medical device markets ever since.